This dominant negative disease mechanism has been suggested for some VEGFR3 variants associated with primary lymphedema.26 The variants in this category predominantly associated with LRFH with fetal hydrops, lymphovenous abnormalities, and ASD, some with very mild symptoms (e.g., FH3). The gene discussed is FLT4; the disease is hydrops fetalis.